Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats

Neuroscience Letters

Volumn 214, Issue 1, 1996, Pages 61-64

  Kobayashi, Satoru ^a   Ohta, Minoru ^a   Miyasaka, Kyoko ^a   Funakoshi, Akihiro ^b  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

ChoIecystokinin A receptor; Cholecystokinin; Exploratory behavior; Open field test

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; GENE MUTATION; LOCOMOTION; MALE; NONHUMAN; NORTHERN BLOTTING; OPEN FIELD TEST; PRIORITY JOURNAL; RAT;

EID: 0030590255     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12881-0     Document Type: Article

References (23)

1. [1] Booth, F.G. and Clark, J.B., A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain, Biochem. J., 176 (1978) 365-370.
2. [2] Crawley, J.N., Cholecystokinin-dopamine interactions, Trends Pharmacol. Sci., 142 (1991) 232-236.
3. [3] Crawley, J.N., Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway, J. Neurosci., 12 (1992) 3380-3391.
4. [4] Dockray, G.J., Immunochemical evidence of cholecystokinin-like peptides in brain, Nature (London), 264 (1976) 568-570.
5. [5] Funakoshi, A., Kono, A. and Miyasaka, K., Lack of appropriate citation (Letter to the Editor), Am. J. Physiol., 33 (1996) E373.
6. [6] Funakoshi, A., Miyasaka, K., Jimi, A., Kawanami, T., Takata, Y. and Kono, A., Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long -Evans Tokushima Fatty-OLETF rats), Biochem, Biophys. Res. Commun., 199 (1994) 482-488.
7. [7] Funakoshi, A., Miyasaka, K., Shinozaki, H., Masuda, M., Kawanami, T., Takata, Y. and Kono, A., An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor, Biochem. Biophys. Res. Commun., 210 (1995) 787-796.
8. [8] Funakoshi, A., Nakano, I., Shinozaki, H., Tateishi, K., Hamaoka, T. and Ibayashi, H., High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain. Am. J. Gastroenterol., 81 (1986) 1174-1178.
9. [9] Funakoshi, A., Tanaka, A., Kawanami, T., Tateishi, K., Miyasaka, K. and Kono, A., Expression of the cholecystokinin (CCK) precursor gene in rat tissues, J. Gastroenterol., 29 (1994) 125-128.
10. [10] Hamilton, M.E. and Freeman, A.S., Effects of administration of cholecystokinin into VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats. Brain Res., 688 (1995) 134-142.
11. [11] Hill, D.R., Campell, N.J., Shaw, T.M. and Woodruff, G.N., Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists, J. Neurosci., 7 (1987) 2967-2977.
12. 3H-MK 329, J. Neurosci., 10 (1990) 1070-1081.
13. [13] Hughes, J., Boden, P., Costall, B., Domeney, A., Kelly, E., Horwell, D.C., Hunter, J.C., Pinnock, R.D. and Woodruff, G.N., Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity, Proc. Natl. Acad. Sci. USA, 87 (1990) 6728-6732.
14. [14] Miyasaka, K., Kanai, S., Ohta, M., Kawanami, T., Kono, A. and Funakoshi, A., Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene, Neurosci. Lett., 180 (1994) 143-146.
15. [15] Ohta, M., Tanaka, Y., Masuda, M., Miyasaka, K. and Funakoshi, A., Impaired release of cholecystokinin (CCK) from synaptosomes in old rats, Neurosci. Lett., 198 (1995) 161-164.
16. [16] Rataud, J., Darche, F., Piot, O., Stutzmann, J.M., Böhme, G.A. and Blanchard, J.C., 'Anxiolytic' effect of CCK-antagonists on plusmaze behavior in mice, Brain Res., 548 (1991) 315-317.
17. [17] Setnikar, I., Bani, M., Cereda, R., Chiste, R., Makovec, F., Pacini, M.A. and Rebel, L., Anticholecystokinin activities of loxiglumide, Arzneim.-Forsch./Drug Res., 37 (1987) 1168-1171.
18. [18] Silver, A.J., Flood, J.F., Song, A.M. and Morley, J.E., Evidence of a physiological role for CCK in the regulation of food intake in mice, Am. J. Physiol., 256 (1989) R646-R652.
19. [19] Takata, Y., Takiguchi, S., Funakoshi, A. and Kono, A., Gene structure of rat cholecystokinin type-A receptor, Biochem. Biophys. Res. Commun., 213 (1995) 958-966.
20. [20] Tanaka, Y., Hasegawa, A. and Ando, S., Impaired synaptic functions with aging as characterized by decreased calcium and acetylcholine release, J. Neurosci. Res., 43 (1996) 63-70.
21. [21] Vasar, E., Harro, J., Lang, A., Pold, A. and Soosaar, A., Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse, Psychopharmacology, 105 (1991) 393-399.
22. [22] Wank, S.A., Harkins, R., Jensen, R., Shapira, H., Weerth, A. and Slattery, T., Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas, Proc. Natl. Acad. Sci. USA, 89 (1992) 3125-3129.
23. [23] Wank, S.A., Pisegna, J.R. and De Weerth, A., Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression, Proc. Natl. Acad. Sei. USA, 89 (1992) 8691-8695.